BLOCKStrain Technology Appoints Dr. Gina Conte as Director of Genetics

Share This Article

Share on facebook
Share on linkedin
Share on twitter
Share on email

VANCOUVERApril 11, 2019 /CNW/ – BLOCKStrain Technology Corp. (TSX:V: DNAX.V) (OTC: BKKSF) (“BLOCKStrain”), creator of the first Blockchain-secured, fully-integrated IP tracking platform for the cannabis industry, today announced it has appointed award-winning geneticist Dr. Gina Conte to the role of Director of Genetics. Dr. Conte brings an extensive amount of expertise to her role, and will provide leadership and direction in business development.

BLOCKStrain Technology Corp. (CNW Group/BLOCKStrain Technology Corp.)

“Dr. Conte brings significant experience and insight to BLOCKStrain, and will provide tremendous strength to our growing cadre of cannabis-based science experts,” said CEO, Robert Galarza. “Her past research into this field has provided forward momentum and knowledge around the genetics and profiling of cannabis strains, and we are excited to have her as a key part of our team as we work diligently to provide both industry participants and consumers with best-in-class technology solutions.”

“BLOCKStrain’s mission to increase transparency and integrity in the cannabis industry aligns strongly with my ongoing interest and specialization in the genetics of cannabis strains,” said Dr. Conte. “I look forward to working closely with BLOCKStrain as they continue to innovate with this industry-best technology platform.”

Dr. Conte is currently the Chief Scientific Officer at Lighthouse Genomics Inc. where she leads the company in the development and implementation of genomic services for the certification and verification of cannabis strains. Dr. Conte is also Co-founder and Chief Scientific Officer of Illuminate Data Science Inc. where she leads a research program to model the effects of cannabis strains and products on the therapeutic efficacy and experience using innovative machine learning.

In connection with this appointment BLOCKStrain has agreed to grant Dr. Conte stock options to acquire up to 250,000 common shares in the capital of BLOCKStrain, subject to the terms of a stock option agreement to be entered into by the parties.

About BLOCKStrain:

BLOCKStrain has developed the first integrated blockchain platform to register and track intellectual property in the cannabis industry. BLOCKStrain’s technology allows cannabis growers and breeders to identify and secure rights to their intellectual property. It also streamlines the administrative process and reduces the costs of genetic and mandatory quality-control testing for legal cannabis. BLOCKStrain’s technology is proprietary, immutable and cryptographically secure, thereby establishing a single-source, accurate, validated, and permanent account for cannabis strains from ownership to market.

Forward-Looking Information:

The forward-looking information in this news release is based upon expectations, estimates, projections, assumptions and views of future events which management believes to be reasonable in the circumstances. Forward-looking information includes estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of fact. Forward-looking statements in this news release include statements regarding: Gina L. Conte’s anticipated role with BLOCKStrain and that her expertise will benefit BLOCKStrain. Forward-looking information necessarily involves known and unknown risks, including, without limitation, risks associated with general economic conditions; adverse industry events; loss of markets; changes to the growth and size of the cannabis industry;future legislative and regulatory developments; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; the cannabis industry in Canada generally; the ability of BLOCKStrain to implement its business strategies; competition; and other risks. These forward-looking statements are made as of the date hereof and BLOCKStrain disclaims any intent or obligation to update publicly any forward-looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

SOURCE BLOCKStrain Technology Corp.

View original content to download multimedia: https://www.newswire.ca/en/releases/archive/April2019/11/c0428.html

BLOCKStrain Technology Corp. Robert Galarza, Chief Executive Officer and Director; Investor Inquiries: Crystal Quast Bullseye Corporate, 1-844-656-3629, Quast@BullseyeCorporate.com; Media Inquiries: Corey Herscu RNMKR, 416-410-0404, corey@rnmkr.agencyCopyright CNW Group 2019

Source: Canada Newswire (April 11, 2019 – 7:30 AM EDT)

More To Explore

Recent News

© 2019-2024, TruTrace Technologies, Inc. | All Rights Reserved.